Myriad Genetics sell JPMorgan Chase & Co.
Start price
07.08.24
/
50%
€23.80
Target price
07.08.25
€18.31
Performance (%)
-78.57%
End price
08.08.25
€5.10
Summary
This prediction ended on 08.08.25 with a price of €5.10. JPMorgan_Chase___Co_ correctly predicted massive losses of -78.57% for Myriad Genetics. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Myriad Genetics | -7.200% | -7.200% | -56.391% |
| iShares Core DAX® | -1.212% | 1.925% | 17.589% |
| iShares Nasdaq 100 | -4.714% | -1.810% | 0.450% |
| iShares Nikkei 225® | -2.976% | -2.660% | 10.156% |
| iShares S&P 500 | -2.744% | -0.448% | 0.320% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Myriad Genetics diskutieren
Myriad Genetics, Inc. (NASDAQ: MYGN) had its price target raised by analysts at JPMorgan Chase & Co. from $17.00 to $20.00. They now have an "underweight" rating on the stock.
Ratings data for MYGN provided by MarketBeat
In the thread Trading Myriad Genetics
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten